{
  "id": 6470638,
  "title": "Early MS treatments differ most in relapses and MRI lesions, not disability",
  "url": "https://urgent.news/2026/09/09/early-ms-treatments-differ-most-in-relapses-and-mri-lesions-not",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-09T20:00:04.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-early-ms-treatments-differ-relapses.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after two years, based on the first treatment they used, according to a study published Sept. 9, 2026, in Neurology Open Access. The study found that B-cell-depleting therapies, which are given through an infusion in a vein and lower the number of B cells, a type of…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}